NRC Corporation (Stock Code: NRC) has just approved the establishment of NRC Pharma Co., Ltd. with a chartered capital of VND 50 billion. Headquartered in Tan Dinh Ward, Ho Chi Minh City, NRC Pharma is the third subsidiary of NRC.
NRC Pharma has registered 24 business sectors. Its primary focus includes trading in cosmetics, pharmaceuticals, and wholesale drugs, as well as dealing in miscellaneous goods, stationery, food, personal items, and household goods. The company also acts as an agent for vaccine and medical biological product sales.
Mr. Trinh Van Bao, Deputy General Director of NRC, has been appointed as the Chairman of the Board of Directors and legal representative of NRC Pharma. This move comes just days after NRC changed its name from Danh Khoi Joint Stock Group Company to NRC Joint Stock Group Company, effective July 31st.
NRC Corporation establishes NRC Pharma with a chartered capital of VND 50 billion.
NRC Corporation was established in 2006 as Netland Real Estate Information Services Joint Stock Company. In 2016, the company changed its name to Netland Real Estate Joint Stock Company. In April 2018, it was listed and traded on the Hanoi Stock Exchange (HNX) under the stock code NRC. In 2020, the company changed its name to Danh Khoi Joint Stock Group Company before becoming NRC Joint Stock Group Company today.
NRC has recently endured a challenging period in its business. Last year, the company incurred a post-tax loss of over VND 137 billion and had to request a name change from shareholders. For this year, NRC targets a consolidated total revenue and other income of VND 959 billion and a pre-tax profit of VND 25 billion.
At the 2025 Annual General Meeting on June 24th, NRC approved a plan to issue over 92.5 million shares with a par value of VND 10,000 per share to restructure its finances, reduce debt, increase assets, and supplement capital for its operations in the 2025-2026 period. Many investors expressed concerns about the significant loss and tax debt. They also questioned the feasibility of the share issuance plan, as NRC’s current share price is VND 4,500, while the issuance price is set at VND 10,000.
In the second quarter of this year, NRC recorded a modest revenue of over VND 4 billion, a 32% decrease compared to the same period last year. However, the company escaped losses thanks to a provision reversal of over VND 25 billion, resulting in a net profit of more than VND 4 billion, a 7% decrease year-on-year. In the first six months of the year, NRC achieved a revenue of over VND 11 billion (a 4.4-fold increase compared to the same period last year) due to consulting and enterprise management services, which contributed nearly VND 9 billion. The company’s pre-tax profit was over VND 8 billion, a 51% decrease compared to the previous year.
As of June 30th, NRC’s total assets amounted to over VND 1,895 billion, a 2% decrease from the beginning of the year. Short-term receivables accounted for 22% of the capital source, totaling nearly VND 411 billion. The company’s payables stood at nearly VND 735 billion.
Revolutionizing the Industry: NRC Expands Horizons with a New Name and Venture into Pharmaceuticals
The Board of Directors of NRC Corporation (HNX: NRC) has approved the establishment of NRC Pharma LLC with a chartered capital of VND 50 billion. The new subsidiary will be headquartered in Tan Dinh Ward, Ho Chi Minh City, and NRC will contribute the entire capital to this new venture.
The Ultimate Recession-Proof Industry: A $70 Billion Behemoth, with Retail Giants Scrambling to Open Stores in Rural and Urban Areas Alike
The pharmaceutical retail market is often deemed “recession-proof”, owing to the consistent demand for pharmaceuticals, which remains imperative despite macroeconomic fluctuations. In the context of Vietnam, with its aging population and growing middle class, the demand for healthcare, and by extension, the pharmaceutical industry, is experiencing unwavering growth, as highlighted by Vietdata, a prominent provider of reports on the Vietnamese economy.
“DHG Pharma: 5 Decades of Pride, Gratitude and Aspiration”
On August 31st, DHG Pharma, a leading pharmaceutical company in Can Tho, organized its annual traditional walk alongside a celebration of its 50th anniversary. The theme, “50 Years of Unceasing Aspirations,” commemorated the proud journey of DHG Pharma’s generations through the decades.
What Northern Province is Home to the $10 Billion Pharma Park?
This is regarded as one of the largest pharmaceutical projects in Vietnam, spanning an impressive 960 hectares. With a total investment of 10 to 20 billion USD from two Indian enterprises, this project is set to make a significant impact on the industry.
